ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 745,72
0,03%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Lexeo Therapeutics Inc (LXEO)

  7. Lexeo Therapeutics Inc (LXEO) Actualités

LXEO

Lexeo Therapeutics (LXEO)

Lexeo Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:LXEO
DateHeureSourceTitreSymboleSociété
22/05/202423h03Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
14/05/202422h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
13/05/202423h14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
09/05/202413h09Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:LXEOLexeo Therapeutics Inc
09/05/202413h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LXEOLexeo Therapeutics Inc
09/05/202413h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LXEOLexeo Therapeutics Inc
09/05/202413h00GlobeNewswire Inc.Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational HighlightsNASDAQ:LXEOLexeo Therapeutics Inc
07/05/202413h30GlobeNewswire Inc.Lexeo Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:LXEOLexeo Therapeutics Inc
22/04/202413h30GlobeNewswire Inc.Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia CardiomyopathyNASDAQ:LXEOLexeo Therapeutics Inc
16/04/202413h30GlobeNewswire Inc.Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia CardiomyopathyNASDAQ:LXEOLexeo Therapeutics Inc
13/03/202421h22GlobeNewswire Inc.Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity FinancingNASDAQ:LXEOLexeo Therapeutics Inc
11/03/202421h09Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LXEOLexeo Therapeutics Inc
11/03/202414h29Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:LXEOLexeo Therapeutics Inc
11/03/202412h42GlobeNewswire Inc.Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsNASDAQ:LXEOLexeo Therapeutics Inc
11/03/202412h30GlobeNewswire Inc.Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity FinancingNASDAQ:LXEOLexeo Therapeutics Inc
05/02/202413h00GlobeNewswire Inc.Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive AppointmentsNASDAQ:LXEOLexeo Therapeutics Inc
03/01/202413h00GlobeNewswire Inc.Lexeo Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LXEOLexeo Therapeutics Inc
18/12/202313h00GlobeNewswire Inc.Lexeo Therapeutics Granted FDA Fast Track Designation and Orphan Drug Designation for LX2020, an AAV-Based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy (ACM)NASDAQ:LXEOLexeo Therapeutics Inc
11/12/202313h00GlobeNewswire Inc.Lexeo Therapeutics Reports Third Quarter 2023 Financial Results and Operational HighlightsNASDAQ:LXEOLexeo Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:LXEO

Dernières Valeurs Consultées

BIT
P12VB2
BNP PARIBAS ISSUANCE
BIT
S27667
Societe Generale Effekten
BIT
BIM
Banca Intermobiliare
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés